Celecoxib + Placebo

ApprovedCompleted

0 views this week 0 watching⚡ Active

Interest: 43/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Osteoarthritis, Knee

Conditions

Osteoarthritis, Knee

Trial Timeline

Dec 1, 2003 → Sep 1, 2004

NCT ID

NCT00640627

About Celecoxib + Placebo

Celecoxib + Placebo is a approved stage product being developed by Pfizer for Osteoarthritis, Knee. The current trial status is completed. This product is registered under clinical trial identifier NCT00640627. Target conditions include Osteoarthritis, Knee.

What happened to similar drugs?

20 of 20 similar drugs in Osteoarthritis, Knee were approved

Approved (20) Terminated (1) Active (0)

✅NISEDr. Reddy's LaboratoriesApproved

✅Duloxetine + Sugar pillEli LillyApproved

✅Capsaicin Topical SolutionAstellas PharmaApproved

✅duloxetineEli LillyApproved

✅ImrecoxibJiangsu Hengrui MedicineApproved

✅Etoricoxib (Arcoxia) + Sugar pillMerckApproved

✅zoledronic acidNovartisApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (11)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01186887	Pre-clinical	Completed	Feb 1, 2009	Apr 1, 2013	Pain
NCT00583453	Phase 2	Completed	Oct 1, 2007	May 1, 2016	Tonsillitis
NCT00359151	Approved	Terminated	Nov 1, 2006	Jul 1, 2007	Osteoarthritis
NCT00585312	Phase 3	Terminated	Sep 1, 2006	Oct 1, 2013	Adenomatous Polyposis Coli
NCT00300729	Phase 3	UNKNOWN	May 1, 2006	Sep 1, 2010	Non-Small Cell Lung Cancer
NCT00640627	Approved	Completed	Dec 1, 2003	Sep 1, 2004	Osteoarthritis, Knee
NCT00698204	Phase 2	Completed	Jul 1, 2003	Dec 1, 2013	Oral Mucositis
NCT00639483	Phase 2	Completed	Mar 1, 2003	Jan 1, 2004	Schizophrenia
NCT00471341	Approved	Completed	Jul 1, 2002	Dec 1, 2004	Hypertension and Coronary Artery Disease
NCT00582660	Phase 2	Completed	Dec 1, 2001	Jun 1, 2008	Colorectal Adenoma
NCT02840162	Phase 2	Terminated	May 1, 2001	May 1, 2011	Adenocarcinoma of the Prostate

Competing Products

20 competing products in Osteoarthritis, Knee

See all competitors

Product	Company	Stage	Hype Score
NISE	Dr. Reddy's Laboratories	Approved	40
NISELAT	Dr. Reddy's Laboratories	Pre-clinical	23
Duloxetine + Placebo	Eli Lilly	Phase 3	40
LY2828360 + Placebo	Eli Lilly	Phase 2	35
Investigational Medical Product (IMP) administered in parent study	Eli Lilly	Phase 3	40
Duloxetine + Sugar pill	Eli Lilly	Approved	43
UBX0101 or placebo	Unity Biotechnology	Pre-clinical	8
UBX0101	Unity Biotechnology	Phase 1	19
UBX0101	Unity Biotechnology	Phase 2	25
UBX0101	Unity Biotechnology	Phase 1	19
YH23537 + Celecoxib + YH23537 placebo	Yuhan	Phase 2	35
Sodium hyaluronate + placebo injection	Daiichi Sankyo	Phase 3	32
ASP7962 + Naproxen + Placebo	Astellas Pharma	Phase 2	35
Capsaicin Topical Solution	Astellas Pharma	Approved	43
CGS-200-1 + CGS-200-5 + CGS-200 Vehicle	Astellas Pharma	Phase 2	35
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + Placebo	Sun Pharmaceutical	Phase 2	35
Duloxetine + Placebo	Shionogi	Phase 3	40
Duloxetine	Shionogi	Phase 3	40
ONO-4474 Part A1 + Placebo Part A1 + ONO-4474 Part A2 + Placebo Part A2 + ONO-4474 Part B + Placebo Part B + ONO-4474 Part C + Placebo Part C + ONO-4474 Part D + Placebo Part D	Ono Pharmaceutical	Phase 1	29
ONO-4474 + Placebo matching ONO-4474	Ono Pharmaceutical	Phase 2	27